Leadership Overview
IGI has 6 executives leading key functions including strategy, operational management, global administration, financial oversight, and corporate leadership.
Committed to excellence in gemstone certification, IGI maintains the highest standards for testing and grading fine jewelry while fostering global trust through independent laboratory services.
Committed to excellence in gemstone certification, IGI maintains the highest standards for testing and grading fine jewelry while fostering global trust through independent laboratory services.
Leadership Roles at IGI
Roland Lorie - Chief Executive Officer
Roland Lorie, the Chief Executive Officer at IGI, directs the overarching strategic vision for the world's largest independent laboratory for testing and grading gemstones. Lorie architects long-term growth initiatives while ensuring the integrity of laboratory operations across international markets. By focusing on the expansion of certification services, the Chief Executive Officer maintains the company's reputation for quality and precision. Roland Lorie collaborates with the board to refine service offerings, ensuring alignment with evolving industry demands for transparency in fine jewelry. This leadership role involves monitoring global market trends to sustain competitive advantages in gemstone analysis. Through rigorous oversight of laboratory standards, the Chief Executive Officer drives operational excellence. Ultimately, Lorie secures the firm's position as a trusted authority in the global jewelry sector, fostering confidence among retailers and consumers alike through consistent, high-quality service delivery.

Marc Brauner - Co-Chief Executive Officer
Marc Brauner, the Co-Chief Executive Officer at IGI, manages the operational execution of laboratory testing protocols and service delivery frameworks. Brauner drives the implementation of advanced grading technologies to enhance the accuracy of gemstone assessments. As the Co-Chief Executive Officer, Marc Brauner oversees the integration of standardized procedures across regional facilities to ensure uniformity in quality control. This role requires constant coordination with technical teams to refine testing methodologies for diamonds and colored stones. By optimizing laboratory workflows, the Co-Chief Executive Officer improves efficiency and turnaround times for clients worldwide. Brauner also focuses on scaling service capacity to meet the rising demand for independent certification in emerging markets. Through strategic resource allocation, the Co-Chief Executive Officer supports the company's mission of providing reliable, objective data to the jewelry industry, thereby reinforcing the firm's status as a premier global testing authority.
Tehmasp Printer - Global Chief Executive Officer
Tehmasp Printer, the Global Chief Executive Officer at IGI, directs the international expansion strategy and manages cross-border laboratory operations. Printer architects initiatives to strengthen the company's presence in key jewelry hubs, ensuring consistent service quality across all continents. As the Global Chief Executive Officer, Tehmasp Printer monitors the performance of regional offices to maintain alignment with corporate objectives. This leadership role involves navigating complex regulatory environments to uphold the independence and credibility of gemstone grading services. By fostering partnerships with major jewelry retailers and manufacturers, the Global Chief Executive Officer drives market penetration and brand recognition. Printer also prioritizes the adoption of innovative digital certification tools to enhance client accessibility. Through strategic leadership, the Global Chief Executive Officer ensures the firm remains at the forefront of the industry, providing essential verification services that support the global trade of fine jewelry and gemstones.

XiaoQuan Miao - Group Chief Financial Officer
XiaoQuan Miao, the Group Chief Financial Officer at IGI, manages the consolidated financial health and capital structure of the organization. Miao architects fiscal strategies to support the company's extensive laboratory network and service infrastructure. As the Group Chief Financial Officer, XiaoQuan Miao oversees budgeting, financial reporting, and risk management processes to ensure long-term stability. This role involves analyzing investment opportunities in new testing technologies and facility upgrades to maintain a competitive edge. By optimizing cost structures and revenue streams, the Group Chief Financial Officer supports the firm's growth objectives in the global gemstone market. Miao also coordinates with executive leadership to align financial planning with strategic business goals. Through rigorous financial oversight, the Group Chief Financial Officer ensures the company possesses the resources necessary to uphold its reputation for quality service and extensive experience in the testing and grading of fine jewelry.
Eashwar Iyer - Global Chief Financial Officer
Eashwar Iyer, the Global Chief Financial Officer at IGI, directs the international financial operations and treasury functions of the laboratory network. Iyer architects robust financial controls to support the company's expansive footprint in the gemstone testing industry. As the Global Chief Financial Officer, Eashwar Iyer monitors cash flow, tax compliance, and currency management across diverse geographic regions. This role involves evaluating the financial viability of new laboratory locations and service expansions to ensure sustainable growth. By providing data-driven insights, the Global Chief Financial Officer assists the executive team in making informed decisions regarding market investments. Iyer also manages relationships with financial institutions to secure the capital required for technological advancements in grading equipment. Through meticulous financial stewardship, the Global Chief Financial Officer ensures the firm maintains the fiscal strength needed to provide world-class, independent certification services to the global jewelry trade.
Jeffrey Bennett - President
Jeffrey Bennett, the President at IGI, directs the day-to-day business activities and client relations for the organization. Bennett architects programs to enhance service delivery and customer satisfaction within the gemstone grading sector. As the President, Jeffrey Bennett oversees the implementation of corporate policies and ensures that laboratory operations meet the high standards expected by the jewelry industry. This role involves engaging with key stakeholders to promote the value of independent certification and transparency. By streamlining internal processes, the President improves the overall efficiency of service offerings for retailers and manufacturers. Bennett also focuses on developing talent within the organization to maintain technical expertise in gemstone analysis. Through active management of business development initiatives, the President drives the company's mission to provide reliable, high-quality testing services, ultimately strengthening the firm's position as a leader in the global jewelry market.

Explore Leadership Teams in Business Services
The Neurobiology Department at the University of Maryland School of Medicine focuses on research related to addiction, pain, and aging, addressing critical health issues for the citizens of Baltimore and Maryland. They collaborate with various institutes and centers, including the Kahlert Institute for Addiction Medicine and UM-MIND, to enhance research, training, and outreach programs. Their intended clients include students and researchers in the fields of neuroscience and medicine. The department emphasizes a culture of wellness and belonging within the neuroscience community.
Company Leadership JH
JL
AM
TK
CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites commitment to real world solutions.
Company Leadership RB
KM
KC
Certerra is a technology-enabled testing, inspection, and certification services company that supports new product development, engineering, construction, and infrastructure asset management. The company provides specialized services designed to help clients bring products to market efficiently, verify compliance with applicable codes and standards, manage engineering requirements, and maintain quality throughout project delivery. Its testing, inspection, and certification capabilities support organizations seeking to ensure that products, materials, systems, and construction projects meet required technical, safety, quality, and regulatory standards.
Company Leadership
PS

WCG Clinical Services enhances the quality and efficiency of clinical trials for biopharmaceutical companies, contract research organizations (CROs), and research institutions. They offer a range of solutions including study planning, independent ethical review, and data insights to facilitate the development of new treatments. Their expertise spans the research ecosystem, providing support to sponsors, CROs, sites, and participants. WCG Clinical Services is committed to accelerating research and improving patient outcomes through innovative technology and expert consulting.
Company Leadership GW
PM
TC